R. Cosentini (Milan, Italy), K. Dalhoff (Lubeck, Germany)
Pneumococcal pneumonia in hospitalized patients. Therapeutic implications of resistances to penicillin and erythromycin
|  |
Microbiological consequences of CAP prophylaxis with azithromycin in military conscripts
I. A. Gouchev (Smolensk, Russia)
| |
Clinical features of acute respiratory infections associated with Streptococcus milleri group in the elderly
N. Hirota, E. Sugihara, T. Koyanagi, N. Ono, H. Koga, T. Rikimaru, H. Aizawa (Chikugo, Fukuoka, Kurume, Japan)
| |
Down-regulation of pro-inflammatory response genes of circulating leukocytes in ICU patients with severe pneumonia meeting criteria of systemic inflammatory response syndrome (SIRS)
A. A. Igonin, V. W. Armstrong, E. Wieland, N. B. Lazareva, R. V. Archvadze, M. Oellerich (Moscow, Russia; Goettingen, Germany)
| |
Influenza pneumonia: radiographic and CT findings in 29 patients
N. Takayanagi, Y. Maeno, H. Matsushima, D. Tokunaga, N. Sato, M. Ubukata, K. Kurashima, T. Yanagisawa, Y. Sugita, M. Kanazawa (Kohnan, Moroyama, Japan)
| |
An epidemic of acute pneumonia due to Coxiella burnetii in the public prison of como, Northern Italy
R. Giura, D. Santoro, M. Donghi, L. Pusterla, A. Maspero, P. Antonelli, C. Colombo, R. Mauri (Como, Italy)
| |
Invasive procedures and etiological diagnosis in severe pneumonia: A case study of 20 patients
S. Cordani, S. Calafati, A. Carpenzano, E. Battolla, M. Vignali, A. Manna, P. Canessa (Sarzana, La Spezia, Italy)
| |
Prolonged hospitalization in community-acquired pneumonia. Influence of clinical factors and hospital characteristics
R. Menendez, M. J. Cremades, E. Martinez-Moragon, J. J. Soler, S. Reyes, M. Perpiñá (Valencia, Gandía, Sagunto, Requena, Spain)
| |
Etiology of community acquired pneumonia in India
Z. F. Udwadia, A. V. Doshi, J. M. Joshi, C. S. Rodrigues, S. S. Ladhani (Mumbai, India)
| |
Community-acquired pneumonia in elderly estimated by Fine[ssquopte]s score
S. Raljevic, M. Mitic-Milikic (Belgrade, Yugoslavia)
| |
Antimicrobial susceptibility of common pathogens of the lower respiratory tract in Southern Estonia
A. Altraja, P. Naaber, S. Meriste, A. Kullamaa, H. Leesik (Tartu, Estonia)
| |
Antibiotic therapy of Pneumococcal pneumonia with levofloxacin-a meta-analysis of 4 studies
G. Peiffer, P. Leophonte, J. P. Bru, P. Veyssier (Metz, Toulouse, Annecy, Compiegne, France)
| |
Cost-effectiveness of sequential iv-oral moxifloxacin versus current standard care in community acquired pneumonia to the Belgium health care system
K. Moeremans, L. Annemans (Brussels, Ghent, Belgium)
| |
Effect of a quality improvement plan on the outcome of patients with community acquired pneumonia
L. S. Widjaja, K. L. Khoo, T. K. Lim (Singapore, Singapore)
| |
Severe Chlamydia pneumoniae community-acquired pneumonia
R. Cosentini, P. Tarsia, F. Blasi, C. Ghiringhelli, G. Milani, V. Popescu-Janu, L. Allegra (Milan, Italy)
| |
Community-acquired pneumonia (CAP) in a central hospital: comparison between a group of elderly and non-elderly patients
S. Moreira, A. Coutinho, C. Lucas, E. Pestana, C. Leitao, F. Dias (Lisbon, Portugal)
| |
Use of a specific risk prediction rule for the hospital management of patients with community-acquired pneumonia
L. Richeldi, M. De Guglielmo, D. Giovanardi, F. Marchetti, L. M. Fabbri (Modena, Verona, Italy)
| |
Lower concentration of anti-capsular polysaccharide IgG antibodies (AB) in patients with pneumococcal respiratory tract infections (RTI)
A. de Roux, G. Zysk, S. Wagner, R. R. Reinhard, H. Lode, H. Mauch (Berlin, Duesseldorf, Germany)
| |
Change in the susceptibility pattern of Streptococcus pneumoniae (SP) and risk factors (RF) for antibiotic resistance (AR) in patients with community-acquired pneumonia (CAP)
A. de Roux, M. A. Marcos, J. Puig de la Bellacasa, A. Rano, J. Mensa, S. Ewig, A. Torres (Barcelona, Spain; Bochum, Germany)
| |